| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
7,389 |
7,140 |
$302K |
| 88307 |
|
489 |
479 |
$27K |
| 86077 |
|
741 |
649 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
284 |
252 |
$5K |
| 87207 |
|
297 |
274 |
$3K |
| 88304 |
|
335 |
333 |
$2K |
| 88112 |
|
83 |
83 |
$1K |
| 88342 |
|
72 |
61 |
$931.51 |
| 84484 |
|
61 |
34 |
$309.09 |
| 82962 |
|
77 |
25 |
$258.52 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
147 |
77 |
$240.29 |
| 80053 |
Comprehensive metabolic panel |
101 |
67 |
$221.56 |
| 80050 |
General health panel |
12 |
12 |
$188.98 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
68 |
37 |
$126.77 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15 |
13 |
$79.38 |
| 83735 |
|
51 |
25 |
$73.70 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17 |
17 |
$48.52 |
| 83690 |
|
31 |
27 |
$42.78 |
| 85610 |
|
41 |
25 |
$35.26 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
13 |
$33.48 |
| 84100 |
|
22 |
14 |
$24.69 |
| 81001 |
|
23 |
20 |
$14.49 |
| 81003 |
|
29 |
23 |
$13.95 |
| 80061 |
Lipid panel |
13 |
13 |
$0.00 |
| 86850 |
|
31 |
25 |
$0.00 |